Dive into the archives.
- RegeneRx’s Tβ4 Significantly Improves Functional Recovery in MS Animal Model
BETHESDA, Md.–REGENERX BIOPHARMACEUTICALS, INC. (NYSE Amex:RGN) announced today that researchers at the Henry Ford Health System in Detroit, Michigan, demonstrated for the first time that Tβ4 treatment of EAE (experimental autoimmune encephalomyelitis – an animal model for multiple sclerosis) significantly improves neurological functional recovery. In addition to this neurological benefit, the researchers reported a significant [...]
- Human Protein May Hold Clues to New MS Treatment
Research into Multiple Sclerosis Raises Hopes of New Treatment Scientists at the University of Bristol in the West of England have discovered that a protein present in the human body can resist Multiple Sclerosis (MS). Galanin is a protein which, according to Professor David Wynick, has been recognized for some time as offering protection for [...]
- PROMISING: Genetically Modified Stem Cells Treat Autoimmune Disease
GM stem cells treat autoimmune disease Thursday, 9 April 2009 Wendy Zukerman ABC // Mice with a human equivalent of multiple sclerosis have been successfully treated using genetically modified stem cells, say a group of Australian researchers. The work, led by Dr James Chan of Monash University’s Centre of Inflammatory Diseases, may lead to the [...]
